Updated:
Mizuho Securities Principal Investment
Mizuho Securities Principal Investment is the investment arm of Mizuho Securities. It has made 12 investments, including a Series A - II investment in Suono...
Overview
Mizuho Securities Principal Investment is the investment arm of Mizuho Securities. It has made 12 investments, including a Series A - II investment in Suono Bio on March 25, 2021. The firm has 5 portfolio exits, including C4 Therapeutics, which exited on October 02, 2020.
General information
Firm type
Private Equity
Year founded
2005
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Frequently asked questions
Is Mizuho Securities Principal Investment a traditional private equity fund or a captive investment arm?
It operates as a captive direct investment division of Mizuho Securities, deploying proprietary balance-sheet capital rather than managing third-party committed funds. This makes it structurally closer to a corporate principal investing desk than to a blind-pool general partner. Unlike independent Japanese GPs that must return capital to external limited partners, the unit's investment horizon and exit discipline are governed by Mizuho's internal capital allocation framework and regulatory capital requirements.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: